IGF-1 LR3vsTesamorelin
IGF-1 LR3 vs Tesamorelin — independent comparison of uses, administration, pricing across providers, and key differences. Last reviewed April 21, 2026.
Quick Verdict
Based on clinical evidence and real patient data
A long-acting analog of insulin-like growth factor-1 (IGF-1) with an arginine substitution that reduces binding to IGF-binding proteins, extending its half-life. IGF-1 is the primary downstream mediator of growth hormone's anabolic effects.
An FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Best choice depends on your insurance, budget, and treatment history.Take the quiz to get a personalized recommendation.
IGF-1 LR3 vs Tesamorelin: At a Glance
Full comparison across all key factors.
| Factor | IGF-1 LR3 | TesamorelinALLY PICK |
|---|---|---|
| Category | growth-hormone | growth-hormone |
| Also Known As | Insulin-like Growth Factor-1 Long R3, Long R3 IGF-1 | Egrifta |
| Administration | Subcutaneous or intramuscular injection | Subcutaneous injection |
| Prescription | Required | Required |
| Providers | 3 providers | 4 providers✓ Better |
| Common Uses |
|
|
Data sourced from FDA prescribing information and peer-reviewed clinical trials. Prices reflect telehealth platform costs as of April 21, 2026. See our methodology.
Pricing by Provider
2 providers offer both IGF-1 LR3 and Tesamorelin.
| Provider | IGF-1 LR3 | Tesamorelin | Consultation | Lab Testing |
|---|---|---|---|---|
 | $250/monthly | $350/monthly | Video Telehealth | Yes |
 | $320/monthly | $420/monthly | Video Telehealth | Yes |
 | $55/one-time | Not offered | Async Telehealth | No |
 | Not offered | $380/monthly | Video Telehealth | Yes |
 | Not offered | $349/monthly | Async Telehealth | Yes |
Key Differences
IGF-1 LR3
A long-acting analog of insulin-like growth factor-1 (IGF-1) with an arginine substitution that reduces binding to IGF-binding proteins, extending its half-life. IGF-1 is the primary downstream mediator of growth hormone's anabolic effects.
Tesamorelin
More ProvidersAn FDA-approved growth hormone-releasing factor analog originally indicated for HIV-associated lipodystrophy. Increasingly used off-label for body composition optimization and visceral fat reduction.
Which Is Right for You?
Choose IGF-1 LR3if…
- You want a growth-hormone medication
- You prefer subcutaneous or intramuscular injection administration
- 3 providers available on our platform
- Your primary goal is muscle hypertrophy
- Your primary goal is fat loss
Choose Tesamorelinif…
- You want a growth-hormone medication
- You prefer subcutaneous injection administration
- You want more provider options (4 available)
- Your primary goal is visceral fat reduction
- Your primary goal is growth hormone stimulation
Frequently Asked Questions
What is the difference between IGF-1 LR3 and Tesamorelin?
Which is cheaper, IGF-1 LR3 or Tesamorelin?
Can I switch from IGF-1 LR3 to Tesamorelin?
Medical Disclaimer
This comparison is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. Individual results may vary. The information presented reflects publicly available data and may not account for your specific health situation.